PGNY delivered extraordinary growth with revenue surging 311% to $1.3B and net income jumping 322% to $58.5M, while reducing share buybacks by 73% and outstanding shares declining from 85.4M to 81.9M.
This represents a transformational year for Progyny with revenue crossing the $1B threshold and profitability scaling dramatically alongside the revenue growth. The company appears to have achieved significant operational leverage while simultaneously returning substantial capital to shareholders through buybacks, though the reduced buyback activity in the current period may signal management's focus on reinvestment or cash preservation.
PGNY demonstrated exceptional financial performance with revenue, gross profit, and net income all growing over 300%, indicating strong operational leverage and margin expansion. While the company significantly reduced share buybacks from $300M to $82M and saw cash decline 31% to $112M, the overall balance sheet remained healthy with 22% growth in total assets and stockholders' equity. The dramatic revenue and profitability growth, combined with increased capex investment and reduced share count, suggests a company successfully scaling its platform while efficiently deploying capital.
Net income grew 322.1% — bottom-line growth signals improving overall business health.
Gross profit expanding — improving pricing power or product mix shift toward higher-margin offerings.
Strong top-line growth of 311.3% — accelerating demand or successful expansion into new markets.
Operating leverage kicking in — revenue growth outpacing cost growth, a hallmark of scaling businesses.
Capital expenditure jumped 240.6% — major investment cycle underway; assess returns on deployment.
Buyback activity reduced 72.8% — capital being redeployed elsewhere or cash conservation underway.
Cash declined 30.9% — significant cash burn or deployment; verify adequacy of remaining liquidity runway.
Asset base grew 22.3% — expansion through organic growth, acquisitions, or capital deployment.
Liabilities increased 22.3% — monitor debt-to-equity ratio and interest coverage.
Equity base grew 22.3% — retained earnings accumulation or equity issuance strengthening the balance sheet.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →